Intronic microRNA suppresses endothelial nitric oxide synthase expression and endothelial cell proliferation via inhibition of STAT3 signaling

Molecular and Cellular Biochemistry

Volumn 357, Issue 1-2, 2011, Pages 9-19

  Yan, Limei ^a   Hao, Hong ^b   Elton, Terry S ^b   Liu, Zhenguo ^b   Ou, Hesheng ^b,c  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b OHIO STATE UNIVERSITY   (United States)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cell proliferation; ENOS; Intron; MicroRNA; Repeat polymorphism; STAT3

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MICRORNA; STAT3 PROTEIN; NITRIC OXIDE; NOS3 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIUM CELL; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; PROTEIN EXPRESSION; RNA TRANSLATION; SIGNAL TRANSDUCTION; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE REPEAT;

CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTRONS; MICRORNAS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REPETITIVE SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870455816     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0870-x     Document Type: Article

References (52)

1. Lai EC (2003) MicroRNAs: runts of the genome assert themselves. Curr Biol 13:R925-R936 (Pubitemid 37502516)
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
3. http://microrna.sanger.ac.uk/
4. Abrahante E, Daul AL, Li M, Volk ML, Tennessen JM, Miller EA, Rougvie AE (2003) The Caenorhabditis elegans hunchbacklike gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs. Dev Cell 4:625-637 (Pubitemid 36564894)
5. 0 UTR of the Arabidopsis SBP box gene SPL3 prevents early flowering by translational inhibition in seedlings. Plant J 49:683-693 (Pubitemid 46233086)
6. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104:476-487
7. Asada S, Takahashi T, Isodono K, Adachi A, Imoto H, Ogata T, Ueyama T, Matsubara H, Oh H (2008) Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am J Physiol Heart Circ Physiol 295(6): H2512-H2521
8. Xu P, Vernooy SY, Guo M, Hay BA (2003) The Drosophila microRNA mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13:790-795 (Pubitemid 36531030)
9. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984
10. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R (2008) Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 5710:2728-2736
11. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R (2009) miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28: 1714-1724
12. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14:1902-1910 (Pubitemid 39386503)
13. Ying SY, Lin SL (2004) Intron-derived microRNAs-fine tuning of gene functions. Gene 342:25-28
14. Lin SL, Chang D, Wu DY, Ying SY (2003) A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun 310:754-760 (Pubitemid 37188685)
15. Clement JQ, Qian L, Kaplinsky N, Wilkinson MF (1999) The stability and fate of a spliced intron from vertebrate cells. RNA 5:206-220 (Pubitemid 29079281)
16. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379:726-731
17. Li XM, Dong XP, Luo SW, Zhang B, Lee DH, Ting AK, Neiswender H, Kim CH, Carpenter-Hyland E, Gao TM, Xiong WC, Mei L (2008) Retrograde regulation of motoneuron differentiation by muscle beta-catenin. Nat Neurosci 11:262-268 (Pubitemid 351311800)
18. Tai SC, Robb GB, Marsden PA (2004) Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol 24:405-412 (Pubitemid 38326131)
19. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478-17488 (Pubitemid 23236991)
20. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870 (Pubitemid 29258973)
21. Kim IJ, Bae J, Lim SW, Cha DH, Cho HJ, Kim S, Yang DH, Hwang SG, Oh D, Kim NK (2007) Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res 119:579-585
22. Spoto B, Benedetto FA, Testa A, Tripepi G, Mallamaci F, Maas R, Boeger RH, Zoccali C (2007) An additive effect of endothelial nitric oxide synthase gene polymorphisms contributes to the severity of atherosclerosis in patients on dialysis. Am J Hypertens 20:758-763 (Pubitemid 46936172)
23. Rittig K, Holder K, Stock J, Tschritter O, Peter A, Stefan N, Fritsche A, Machicao F, Häring HU, Balletshofer B (2008) Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type II diabetes. Horm Metab Res 40:13-17 (Pubitemid 351204819)
24. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2:41-45 (Pubitemid 26028071)
25. Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA (2001) Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 22:361-368 (Pubitemid 32592475)
26. Wang J, Dudley D, Wang XL (2002) Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22:e1-e4
27. Potenza MA, Gagliardi S, Nacci C, Carratu' MR, Montagnani M (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16:94-112
28. Nikitenko LL (2009) Vascular endothelium in cancer. Cell Tissue Res 335:223-240
29. Higashi Y, Noma K, Yoshizumi M, Kihara Y (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73:411-418
30. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044 (Pubitemid 24348244)
31. Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Zhang Y, Coselli J, Wang XL (2008) Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem 283:14685-14693
32. Zhang MX, Ou H, Shen YH, Wang J, Wang J, Coselli J, Wang XL (2005) Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci USA 102:16967-16972 (Pubitemid 41692667)
33. Ou H, Shen YH, Utama B, Wang J, Wang X, Coselli J, Wang XL (2005) Effect of nuclear actin on endothelial nitric oxide synthase expression. Arterioscler Thromb Vasc Biol 25:2509-2514 (Pubitemid 43732271)
34. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86 (Pubitemid 38055775)
35. Liu W, Tang F, Deng Y, Li X, Lan T, Zhang X, Huang H, Liu P (2009) Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol Cell Biochem 325:99-105
36. Chau MN, El Touny LH, Jagadeesh S, Banerjee PP (2007) Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis 28:2282-2290 (Pubitemid 350111586)
37. Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, Morishita R (2003) Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108:2250-2257 (Pubitemid 37363043)
38. Dudzinski DM, Michel T (2007) Life history of eNOS: partners and pathways. Cardiovasc Res 75:247-260 (Pubitemid 46961923)
39. Barik S (2008) An intronic microRNA silences genes that are functionally antagonistic to its host gene. Nucleic Acids Res 36:5232-5241
40. Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, Fabris S, Deliliers GL, Neri A (2008) An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics 1:37
41. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798 (Pubitemid 38058492)
42. Clanton-Arrowood K, McGurk J, Schroeder SJ (2008) 3' terminal nucleotides determine thermodynamic stabilities of mismatches at the ends of RNA helices. Biochemistry 47:13418-13427
43. Sethupathy P, Collins FS (2008) MicroRNA target site polymorphisms and human disease. Trends Genet 24:489-497
44. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y, Shen H (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118:2600-2608 (Pubitemid 351949787)
45. Schaefer LK, Ren Z, Fuller GN, Schaefer TS (2002) Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21:2058-2065 (Pubitemid 34270894)
46. Brantley EC, Benveniste EN (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6:675-684
47. Chen SH, Murphy DA, Lassoued W, Thurston G, Feldman MD, Lee WM (2008) Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther 7:1994-2003
48. Wincewicz A, Sulkowska M, Koda M, Leśniewicz T, Kanczuga-Koda L, Sulkowski S (2007) STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers. Folia Histochem Cytobiol 45:81-86 (Pubitemid 46947836)
49. Bartoli M, Gu X, Tsai NT, Venema RC, Brooks SE, Marrero MB, Caldwell RB (2000) Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem 275:33189-33192
50. Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB (2003) VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17:1562-1564
51. Saura M, Zaragoza C, Bao C, Herranz B, Rodriguez-Puyol M, Lowenstein CJ (2006) Stat3 mediates interleukin-6 [correction of interleukin-6] inhibition of human endothelial nitric-oxide synthase expression. J Biol Chem 281:30057-30062 (Pubitemid 44537013)
52. Sud N, Kumar S, Wedgwood S, Black SM (2009) Modulation of PKCdelta signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3. Am J Physiol Lung Cell Mol Physiol 296:L519-L526